Barnaby Balmforth
Vorstandsvorsitzender bei Biofidelity Ltd.
Profil
Barnaby Balmforth is the founder and current Chief Executive Officer of Biofidelity Ltd., a company founded in 2019.
He previously worked as the Chief Operating Officer at Base4 Innovation Ltd.
Dr. Balmforth received an undergraduate degree from the University of Oxford and a doctorate from the University of Cambridge.
Aktive Positionen von Barnaby Balmforth
| Unternehmen | Position | Beginn |
|---|---|---|
Biofidelity Ltd.
 Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Vorstandsvorsitzender | 15.02.2019 |
Ehemalige bekannte Positionen von Barnaby Balmforth
| Unternehmen | Position | Ende |
|---|---|---|
Base4 Innovation Ltd.
 Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Geschäftsführer | - |
Ausbildung von Barnaby Balmforth
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Base4 Innovation Ltd.
Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Biofidelity Ltd.
Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
